MedPath

Doxycycline Hyclate

DOXYCYCLINE HYCLATE CAPSULES, USP

Approved
Approval ID

1f8f275a-0ea8-4618-a078-ad450d2a434c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 18, 2021

Manufacturers
FDA

Bi-Coastal Pharma International, LLC

DUNS: 078397428

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Doxycycline Hyclate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42582-216
Application NumberANDA209402
Product Classification
M
Marketing Category
C73584
G
Generic Name
Doxycycline Hyclate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 18, 2021
FDA Product Classification

INGREDIENTS (8)

FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
Doxycycline HyclateActive
Quantity: 100 mg in 1 1
Code: 19XTS3T51U
Classification: ACTIM
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
potassium hydroxideInactive
Code: WZH3C48M4T
Classification: IACT
microcrystalline celluloseInactive
Code: OP1R32D61U
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Doxycycline Hyclate - FDA Drug Approval Details